INSIDE CHINA: Staying whiter than white
This article was originally published in Clinica
Executive Summary
In his first article for Clinica’s new column on the hottest issues concerning the Chinese medical device space, Michael Alper of NeuvoMedica discusses China’s recent corruption clampdown and what medtech execs should do to brace themselves for any potential impact